Bio Works Financials
| BIOWKS Stock | SEK 0.91 0.07 8.33% |
Bio |
Understanding current and past Bio Works Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bio Works' financial statements are interrelated, with each one affecting the others. For example, an increase in Bio Works' assets may result in an increase in income on the income statement.
Please note, the presentation of Bio Works' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio Works' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bio Works' management manipulating its earnings.
Bio Works Stock Summary
Bio Works competes with Genovis AB, Cantargia, Intervacc, C Rad, and Xbrane Biopharma. Bio-Works Technologies AB researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. Bio-Works Technologies AB founded in 2006 and is based in Uppsala, Sweden. Bio Works is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0007387089 |
| Business Address | Virdings all 18, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.bio-works.com |
| Phone | 46 8 56 26 74 30 |
| Currency | SEK - Swedish Kronor |
You should never invest in Bio Works without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bio Stock, because this is throwing your money away. Analyzing the key information contained in Bio Works' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bio Works Key Financial Ratios
Bio Works' financial ratios allow both analysts and investors to convert raw data from Bio Works' financial statements into concise, actionable information that can be used to evaluate the performance of Bio Works over time and compare it to other companies across industries.Bio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio Works's current stock value. Our valuation model uses many indicators to compare Bio Works value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Works competition to find correlations between indicators driving Bio Works's intrinsic value. More Info.Bio Works Technologies AB is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio Works by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio Works' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bio Works Technologies Systematic Risk
Bio Works' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bio Works volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Bio Works Technologies correlated with the market. If Beta is less than 0 Bio Works generally moves in the opposite direction as compared to the market. If Bio Works Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bio Works Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bio Works is generally in the same direction as the market. If Beta > 1 Bio Works moves generally in the same direction as, but more than the movement of the benchmark.
Bio Works Thematic Clasifications
Bio Works Technologies AB is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Bio Works November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bio Works help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bio Works Technologies AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bio Works Technologies AB based on widely used predictive technical indicators. In general, we focus on analyzing Bio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bio Works's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 21.0 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 8.33 |
Complementary Tools for Bio Stock analysis
When running Bio Works' price analysis, check to measure Bio Works' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Works is operating at the current time. Most of Bio Works' value examination focuses on studying past and present price action to predict the probability of Bio Works' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Works' price. Additionally, you may evaluate how the addition of Bio Works to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |